引言在血液系统恶性肿瘤的治疗中，嵌合抗原受体T细胞 (Chimeric Antigen Receptor T cell, CAR-T) ...

在探讨当今最具革命性的癌症治疗手段时，嵌合抗原受体T细胞（Chimeric Antigen Receptor T-cell, ...

Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...

Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today ...

Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results Twenty-eight ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Concurrent statin therapy was associated with significantly improved survival outcomes and reduced neurotoxicity in patients ...

The collaboration leverages uBriGene’s LVV Turbo platform for GMP lentiviral vector manufacturing and regulatory support.

The findings are notable because thrombotic complications are often emphasized in cancer care, yet this analysis found that ...